Dr. Henrickson investigates the mechanisms of T cell dysfunction in monogenic primary immunodeficiency and chronic inflammatory disease, including asthma and obesity, and primary immunodeficiency.
Researchers published the first report of pediatric patients treated with convalescent plasma for SARS-CoV-2 associated acute respiratory distress syndrome.
